AAX-21112-93185
4 vaccinations
11 coded responses
44 check-ins
10 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 271 / NC
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
- 2021-03-02
-
2021-03-03
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Neuropathy peripheral — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: I have neuropathy in my extremities; it seemed to be a little mire active today than usual, more discomfort in both hands and feet.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Survey response — days 1–6 daily, dose 1MedDRA: Discomfort — Feeling: Good · Fatigue or tirednessFree text: There is still some increase in the discomfort I feel in my extremities, as reported yesterday, but it is not as marked today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — days 1–6 daily, dose 1MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: Good · Fever · Chills, Joint pains, Muscle or body achesFree text: Again today, my neuropathy discomfort was more noticeable than in the past several weeks, especially in my feet and ankles.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: Neuropathy peripheral — Feeling: Good · Headache, Fatigue or tirednessFree text: Continued MILD symptoms associated with neuropathy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — day 7, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Fatigue or tirednessFree text: Neuropathy discomfort still somewhat increased.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-24
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event, Unevaluable event — Feeling: Good · Site: PainFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-01
- 2021-04-03
- 2021-04-04
-
2021-04-05
Survey response — day 7, dose 2MedDRA: Insomnia — Feeling: GoodFree text: Slept very poorly.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-12
- 2021-06-28
- 2021-09-27
-
2021-10-03
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-03
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Neuropathy seems more marked than usual.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-10-10
Health check-in — day 7, dose 3Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2022-01-02
- 2022-04-03
-
2022-04-05
Dose 4 — Pfizer-BioNTech
- 2022-04-19
- 2022-04-26
- 2022-05-03
-
2022-05-10
Survey response — day 35, dose 4MedDRA: Pre-existing disease, Psoriasis — Feeling: GoodFree text: Flare-up of my psoriasis.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-17
- 2022-07-05
-
2022-10-08
Survey response — 6 months, dose 4MedDRA: Asthenia, Guillain-Barre syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Generalized weakness, diagnosed as mild Guillain-Barr.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-10-10
-
2023-04-05
Survey response — 12 months, dose 4MedDRA: Deafness unilateral, Heart rate irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-05
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-06
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-10-03 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): I have neuropathy in my extremities; it seemed to be a little mire active today than usual, more discomfort in both hands and feet.
Systemic reaction (other): There is still some increase in the discomfort I feel in my extremities, as reported yesterday, but it is not as marked today.
Systemic reaction (other): Again today, my neuropathy discomfort was more noticeable than in the past several weeks, especially in my feet and ankles.
Systemic reaction (other): Continued MILD symptoms associated with neuropathy.
Release 5 — day 7, dose 1
Systemic reaction (other): Neuropathy discomfort still somewhat increased.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): None
Release 6 — day 7, dose 2
Systemic reaction (other): Slept very poorly.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Neuropathy seems more marked than usual.
Release 11 — day 35, dose 4
Symptoms: Flare-up of my psoriasis.
Release 12 — 6 months, dose 4
Symptoms: Generalized weakness, diagnosed as mild Guillain-Barr.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Deafness unilateral | · | · | ✓ |
| SD | Guillain-Barre syndrome | · | · | ✓ |
| SD | Heart rate irregular | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Psoriasis | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Discomfort | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Neuropathy peripheral | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release